Know how is ZyCoV-D vaccine different from other
ABP News Bureau | 27 Jun 2021 11:28 PM (IST)
The phase II study of the vaccine ZyCoV-D had been conducted in over 1,000 healthy adult volunteers as part of the adaptive phase I/II dose escalation, multi-centric, randomised, double-blind placebo controlled study. The vaccine was found to be safe and immunogenic. Watch video to know more.